Clinical trials
Terminated Phase 1/2 Waldenstrom Macroglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Amgen | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
| Idera Pharmaceuticals, Inc. | 1 |
| Jennifer Amengual | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Northwestern University | 1 |
| Sunesis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Lymphoma, B-Cell, Marginal Zone | 9 |
| Lymphoma, Follicular | 9 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Burkitt Lymphoma | 6 |
| Hodgkin Disease | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.